· Form D filing · Baseline
Reported sold as filed: $1,999,999 · Offering amount as filed: $1,999,999
SEC source checked 29 Oct 2026. This is the issuer’s historical filing, not a current valuation.
View original evidence ↗On its website, the company describes its work as “OncoSmart is our AI-powered, digital transformation platform that optimizes and simplifies the complexities of community cancer clinic scheduling and nurse assignment operations. OncoSmart integrates with…”.
These sources establish that the firm lists the company. The observation date records when RiseFinder captured the relationship; it does not establish when the investment happened.
No tracked VC backing is recorded.
· Form D filing · Baseline
Reported sold as filed: $1,999,999 · Offering amount as filed: $1,999,999
SEC source checked 29 Oct 2026. This is the issuer’s historical filing, not a current valuation.
View original evidence ↗